State Of Wyoming Vertex Pharmaceuticals Inc Transaction History

State Of Wyoming

$592 Million
Q2 2024

A detailed history of State Of Wyoming transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, State Of Wyoming holds 150 shares of VRTX stock, worth $71,685. This represents 0.01% of its overall portfolio holdings.

Number of Shares

150

Holding current value

$71,685

% of portfolio

0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $58,921 - $72,829	150 New	150 $70,000
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $82,663 - $98,973	241 Added 142.6%	410 $166,000
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $57,152 - $61,255	169 New	169 $58,000
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $283 - $323	1 Added 0.15%	688 $216,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $6,572 - $7,394	23 Added 3.46%	687 $198,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $95,019 - $106,018	347 Added 109.46%	664 $192,000
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $94,453 - $117,605	-402 Reduced 55.91%	317 $90,000
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $81,261 - $95,775	367 Added 104.26%	719 $188,000
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $17,878 - $22,568	-101 Reduced 22.3%	352 $77,000
Q3 2021 Feb 14, 2022	BUY	$181.39 - $202.99 $16,506 - $18,472	91 Added 25.14%	453 $82,000
Q3 2021 Feb 11, 2022	SELL	$181.39 - $202.99 $86,523 - $96,826	-477 Reduced 56.85%	362 $65,000
Q2 2021 Feb 14, 2022	BUY	$187.49 - $221.1 $113,431 - $133,765	605 Added 258.55%	839 $169,000
Q2 2021 Feb 11, 2022	SELL	$187.49 - $221.1 $25,873 - $30,511	-138 Reduced 37.1%	234 $47,000
Q1 2021 Feb 08, 2022	BUY	$207.02 - $241.31 $77,011 - $89,767	372 New	372 $80,000

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

Capital World Investors Los Angeles, CA

26.7M
Shares

$12.8 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.2 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.6 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.08 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $123B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account